Homocysteine and Ghrelin Link with Polcystic Ovary Syndrome in Relation to Obesity

Journal of Pediatric and Adolescent Gynecology

Volumn 24, Issue 4, 2011, Pages 211-217

  Altuĝ Şen, Tolga ^a   Köken, Reşit ^a   Narci, Adnan ^a   Yilmazer, Mehmet ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Homocysteine; Insulin resistance; Obesity; Polycystic ovary syndrome

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; FOLLITROPIN; GHRELIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; HYDROXYPROGESTERONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PRASTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOLIC ACID BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADOLESCENT; CASE-CONTROL STUDIES; FEMALE; GHRELIN; GONADAL HORMONES; GONADOTROPINS, PITUITARY; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 79959977642     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2011.02.007     Document Type: Article

References (68)

1. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18:774.
2. Nygard O., Refsum H., Ueland P.M., et al. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998, 67:263.
3. Bar-On H., Kidron M., Friedlander Y., et al. Plasma total homocysteine levels and in subjects with hyperinsulinemia. J Intern Med 2000, 247:287.
4. Giltay E.J., Hoogeven E.K., Elbers J.M., et al. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 1998, 139:197. [letter].
5. Meigs J.B., Jacques P.F., Selhub J., et al. Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care 2001, 24:1403.
6. Bonora E., Tessari R., Micciolo R., et al. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance. Diabetes Care 1997, 20:627.
7. Haffner S.M., D'Agostino R., Mykkanen L., et al. Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study. Stroke 1998, 29:1498.
8. Rewers M., R D'Agostino J., Burke G., et al. Coronary artery disease is associated with low insulin sensitivity independent of insulin levels and cardiovascular risk factors. Diabetes 1996, 45(Suppl 2):52A.
9. Okada E., Oida K., Tada H., et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 1999, 22:484.
10. Boushey C.J., Beresford S.A., Omenn G.S., et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049.
11. Schofl C., Horn R., Schill T., et al. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:4607.
12. Panidis D., Farmakiotis D., Koliakos G., et al. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls. Hum Reprod 2005, 20:2127.
13. Neyzi O., Günöz H., Furman H., et al. Türk çocuklarinda vücut aĝirliĝi, boy uzunluĝu, baş çevresi ve vücut kitle indeksi referans deĝerleri. Çocuk Saĝliĝi ve Hastaliklari Dergisi 2008, 51:1.
14. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
15. Ferriman D., Gallwey J.D. Clinical assesment of body hair growth in women. J Clin Endocrinol Metab 1961, 21:1440.
16. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412.
17. Brun J.F., Raynaud E., Mercier J. Homeostasis model assessment and related simplified evaluations of insulin sensitivity from fasting insulin and glucose. Diabetes Care 2000, 23:1037.
18. Bonora E., Targher G., Alberiche M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000, 23:57.
19. Li X., Lin J.F. Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome. Zhonghua Yi Xue Za Zhi 2005, 85:3266.
20. Legro R.S., Castracane V.D., Kauffman R.P. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004, 59:141.
21. Evans J.L., Maddux B.A., Goldfine I.D. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005, 7:1040.
22. Badawy A., State O., El Gawad SSh, et al. Plasma homocysteine and polycystic ovary syndrome: the missed link. Eur J Obstet Gynecol Reprod Biol 2007, 131:68.
23. Wijeyaratne C.N., Nirantharakumar K., Balen A.H., et al. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?. Clin Endocrinol (Oxf) 2004, 60:560.
24. Schachter M., Raziel A., Friedler S., et al. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 2003, 18:721.
25. Loverro G., Lorusso F., Mei L., et al. The plasma homocysteine levels are increased in polycystic ovary syndrome. Gynecol Obstet Invest 2002, 53:157.
26. Fonseca V., Dicker-Brown A., Ranganathan S., et al. Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 2000, 49:736.
27. Araki A., Sako Y., Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of methyl cobalamin treatment. Atherosclerosis 1993, 103:149.
28. Rajkovic A., Mahomed K., Malinow M.R., et al. Plasma homocysteine concentrations in eclamptic and preeclamptic African women postpartum. Obstet Gynecol 1999, 94:355.
29. Laivuori H., Kaaja R., Turpeinen U., et al. Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol 1999, 93:489.
30. Drzewoski J., Czupryniak L., Chwatko G., et al. Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents. Diabetes Care 1999, 22:2097.
31. Munshi M.N., Stone A., Fink L., et al. Hyperhomocysteinemia following a methionine load in patients with noninsulin-dependent diabetes mellitus and macrovascular disease. Metabolism 1996, 45:133.
32. Folsom A.R., Nieto F.J., McGovern P.G., et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998, 98:204.
33. Smulders Y.M., Rakic M., Slaats E.H., et al. Fasting and postmethionine homocysteine levels in NIDDM: determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care 1999, 22:125.
34. House J.D., Jacobs R.L., Stead L.M., et al. Regulation of homocysteine metabolism. Adv Enzyme Regul 1999, 39:69.
35. McCarty M.F. Increased homocysteine associated with smoking, chronic inflammation, and ageing may reflect acute-phase induction of pyridoxal phosphatase activity. Med Hypoth 2000, 55:289.
36. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998, 338:1042.
37. Dicker-Brown A., Fonseca V.A., Fink L.M., et al. The effect of glucose and insulin on the activity of enzymes in homocysteine metabolism. Diabetes 1999, 48(Suppl 1):A135. (Abstract).
38. Sen T.A. Çocuklarda ve Adölesanlarda Hiperhomosisteinemi Glukoz İntoleransi ve Hiperinsülinemiyle İlişkili mi?. Endokrinolojide Diyalog 2007, 4:163.
39. Egido E.M., Rodriguez-Gallardo J., Silvestre R.A., et al. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 2002, 146:241.
40. Date Y., Nakazato M., Hashiguchi S., et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002, 51:124.
41. Ariyasu H., Takaya K., Tagami T., et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001, 86:4753.
42. Tschöp M., Weyer C., Tataranni P.A., et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50:707.
43. Orio F., Lucidi P., Palomba S., et al. Circulating ghrelin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 2003, 88:942.
44. Pöykkö S.M., Kellokoski E., Hörkkö S., et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003, 52:2546.
45. McLaughlin T., Abbasi F., Lamendola C., et al. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulinsensitive controls. J Clin Endocrinol Metab 2004, 89:1630.
46. Olszanecka-Glinianowicz M., Zahorska-Markiewicz B., Kocełak P., et al. The effect of weight reduction on plasma concentrations of ghrelin and insulin-like growth factor 1 in obese women. Endokrynol Pol 2008, 59:301.
47. Zahorska-Markiewicz B., Mizia-Stec K., Olszanecka-Glinianowicz M., et al. Effect of weight reduction on serum ghrelin and TNFalpha concentrations in obese women. Eur J Intern Med 2004, 15:172.
48. Daghestani M.H., Daghestani M.H., El-Mazny A. Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features. Eur J Obstet Gynecol Reprod Biol. 2011, 155:65-68.
49. Bik W., Baranowska-Bik A., Wolinska-Witort E., et al. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome. Gynecol Endocrinol 2007, 23:325.
50. Pagotto U., Gambineri A., Vicennati V., et al. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab 2002, 87(12):5625-5629.
51. Micic D., Sumarac-Dumanovic M., Kendereski A., et al. Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome. J Endocrinol Invest 2007, 30:820.
52. Moran L.J., Noakes M., Clifton P.M., et al. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab 2004, 89:3337.
53. Wasko R., Komarowska H., Warenik-Szymankiewicz A., et al. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome. Horm Metab Res 2004, 36:170.
54. Messini C.I., Dafopoulos K., Chalvatzas N., et al. Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle. Hum Reprod 2009, 24:976-981.
55. Kluge M., Uhr M., Bleninger P., et al. Ghrelin suppresses secretion of FSH in males. Clin Endocrinol (Oxf) 2009, 70:920.
56. Kluge M., Schüssler P., Uhr M., et al. Ghrelin suppresses secretion of luteinizing hormone in humans. J Clin Endocrinol Metab 2007, 92:3202.
57. Fernández-Fernández R., Tena-Sempere M., Aguilar E., et al. Ghrelin effects on gonadotropin secretion in male and female rats. Neurosci Lett 2004, 362:103.
58. Boushey C.J., Beresford S.A.A., Omenn G.S., et al. A quantitative assesment of plasma homocysteine as a risk factor for vascular disease, Probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049.
59. Hankey G.J., Eikelboom J.W. Homocysteine and vascular disease. Lancet 1999, 354:1475.
60. Brower I.A., van Dusseldorp M., Thomas C.M., et al. Low-dose folic acid supplementation decreases plasma homocysteine concentration: a randomized trial. Am J Clin Nutr 1999, 69:99.
61. Pancharunti N., Lewis C.A., Sauberlich H.E., et al. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994, 59:940.
62. Oshaug A., Bugge K.H., Refsum H. Diet, an independent determinant for plasma total homocysteine: a cross sectional study of Norwegian workers on platforms in the North Sea. Eur J Clin Nutr 1998, 52:7.
63. Liese A.D., Mayer-Davis E.J., Haffner S.M. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998, 20:157.
64. Munshi M.N., Stone A., Fink I., et al. Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease. Metabolism 1996, 45:133.
65. Robinson S., Henderson A.D., Gelding S.V., et al. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf) 1996, 44:277.
66. Randeva H.S., Lewandowski K.C., Drzewoski J., et al. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:4496.
67. Talbott E., Guzick D., Clerici A., et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 1995, 15:821.
68. Dahlgren E., Janson P.O. Long-term health implications for women with poycystic ovary syndrome. Polycystic Ovary Syndrome 2000, 70-79. Cambridge University Press, Cambridge. G.T. Kovacs (Ed.).